Abstract Aggregation of the amyloid β-peptide (A β) into insoluble fibrils is a key pathological event in Alzheimer's disease. Zn(II) ion induces significant Aβ aggregation at nearly physiological concentrations in vitro. In order to explore the induce mechanism, the possible binding modes of Zn(II) in Aβ peptide are studied by molecular modeling method. First, the Aβ species containing 1,2,4 and 12 peptides are established respectively. And next a Zn(II) ion is manually hold the different sits of the Aβ species based on the experimental data and subsequently the coordinate atom and number are assigned. Finally, the optimum binding site is found by the system energy minimization. Modeling results show that in soluble Zn(II) complex, Nτ of imidazole ring of His14, O of carbonyl of main-chain, and two O of water occupy the four ligand positions of the tetrahedral complex; in the aggregation of Aβ, the His13(Nτ)-Zn(II)-His14(Nτ) bridges are formed by Zn(II) cross-linking action. Therefore, the possible Zn(II) binding mode obtained by the studies will be helpful to reveal the form mechanism of pathogenic aggregates in brain.
Alzheimer's disease (AD) is a progressive neurodegenerative illness relative to aging. One of the major pathological characters is that senile plaques (SP) occur in the brains of patients. Amyloid β-peptide (Aβ) is the major constituent of senile plaques. The peptide is produced from a precursor membrane protein (APP) by normal proteolytic processing and is released into extracellular fluids as a soluble peptide of 39-42 amino acids [1, 2] . For AD patients, Aβ aggregates and accumulates to form SP cores, moreover, the SP cores have been colocalized with numerous other associated protein and nonprotein components to form SPs, whose extensive depositions cause neurodegeneration [3] . It has been reported that imbalances of metal ions in brain may be related to the pathogenesis of AD. For example, a recent microparticle-induced X-ray emission analysis has shown that Zn and Cu are significantly concentrated in the neurophil of AD patients and are further concentrated within the core and periphery of SPs [4] . Effects of metal ions on the aggregation of human Aβ have been studied in vitro [5] [6] [7] . Al, Fe, Cu and Zn are known to promote aggregation of Aβ. Among them, Zn induces significantly Aβ aggregation at nearly physiological concentrations of the metal ion. Therefore, there has been increasing attention to study the mechanism of Zn ions inducing the aggregation of Aβ. Zn(II) induces synthetic Aβ aggregation in a neutral pH and reversible manner. Zn(II) also selectively induces the rapid aggregation of endogenous Aβ in cerebrospinal fluid. In addition, the concentrations of Zn(II) in multiple brain regions, such as cortex and hippocampus, are elevated in AD patients compared to their age-matched normal people. Up to 300 μmol Zn(II) is released into the extracellular space during neurotransmission in the hippocampus, which may be sufficient to induce aggregation of Aβ. After transient forebrain ischemis, which has relation with Aβ aggregation, degenerating neuron shows a large increase in Zn(II) [8] . Therefore, Zn(II) appears to may have a direct role in the aggregation of human Aβ, however, no clear date reveals the Zn(II) binding sites on human Aβ. Chemical modification and mutation studies have provided some information on the metal binding sites of Aβ. The ability of Zn(II) to aggregate human Aβ is diminished by modifying all the three histidine residues at positions 6, 13 and 14 with diethyl pyrocarbonate [9] ; Raman spectra, CD spectra and fluorescence spectra also confirm that the strong interaction between the histidine residues and Zn(II) exists [8] . Although these findings suggest that one or more of the histidine residues is involved in Aβ aggregation, a detailed Zn(II) binding mode is still little known.
In this paper, we have explored the possible Zn(II) binding modes of synthetic Aβ in soluble complexes and insoluble aggregates by molecular modeling. The His13 and His14 of Aβ are considered to be main ligands. Under the molecular mechanics calculation the following results are obtained: in soluble Zn(II) complexes, Nτ of imidazole ring of His14, O of carbonyl of main-chain, and two O of water occupy the four ligand positions of the tetrahedral complex; in the polymerizing process of Aβ, the His13(Nτ)-Zn(II)-His14(Nτ) bridges are formed by Zn(II) cross-linking action.
Models and parameters

Model construction
The composition and structure of intact SP cores has remained relatively modest. The reason for this is easily understood, and there are almost no techniques available to provide "hard" structural and chemical data on individual biological assemblies with dimensions in the range of 5 μm. Most of the conclusions about the structures of metal binding Aβ are inferential. Electron microscopic studies indicate that fibrils from the plaques are 4-8 nm in diameter and composed of two 2-4 nm filaments. And the filament structure is consisted of Aβ peptides with repeated distances at 0.48 and 1.06 nm [10] . On the basis of the orderly Aβ structure in the fibrils the restrained theory model of Aβ filaments could be constructed. Considering that the calculations for full length β-amyloid (39-42 amino acids) need a lot of computer time and resources to find the Zn(II) optimum binding sites and get the possible structure of Aβ fibrils with Zn(II), a simpler and more practical model needs to be defined. Recently, Morgan [11] has synthesized a shortened variant, YFVHHQLVFFA: Aβ(10-21). By a measure of the rate of fibril formation obtained by plotting the intensity of small angle neutron scattering (SANS), he has successfully insighted into the metal Zn switch for the aggregation of Aβ(10-21). This peptide Aβ(10-21) not only contains the His13 and His14 residues implicated in metal binding but also maintains the overall amphiphilic distribution of amino acids, polar N-terminal and nonpolar C-terminal residues that exist in Aβ(39-42). Here, the Aβ(10-21) is selected to become a simuland of . And the starting geometry of Aβ fibril filament is constructed by using the Aβ(10-21), as shown in the following process: three Aβ(10-21) peptides are hold with face to face distances of 0.5 nm so as to form a β-pleated sheet with intermolecular H-bonds. In our model, two normal types of β-sheet, parallel (Φ = −119°, Ψ = +113°) and anti-parallel (Φ = −139°, Ψ = +135°) are established. Finally, four β-sheets possessing the same secondary structure combine to form a cuboid Aβ fibril, as shown in fig. 1 .
